Financhill
Back

Sarepta Therapeutics Vs. Mirum Pharmaceuticals Industry Stock Comparison

Sell
37

SRPT
Sarepta Therapeutics

Last Price:
127.11
Seasonality Move:
0.19%
Sell
40

MIRM
Mirum Pharmaceuticals

Last Price:
39.35
Seasonality Move:
5.99%
Sell
37
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Mirum Pharmaceuticals (MIRM) is a Sell

Is Mirum Pharmaceuticals a Buy, Sell or Hold?

  • The current Mirum Pharmaceuticals [MIRM] share price is $37.93. The Score for MIRM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • MIRM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $125.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

MIRM Stock Price Chart

What is Mirum Pharmaceuticals's stock price today?

  • The Mirum Pharmaceuticals share price today is $37.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.92 Sell
Relative Strength Index (14 RSI): 32.69 Sell
Chaikin Money Flow: -233066 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (127.43 - 139.51) Sell
Bollinger Bands (100): (124.47 - 147.63) Sell

MIRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 36.81 Sell
Chaikin Money Flow: -512602 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.01 Sell
20-day SMA: 132.96 Sell
50-day SMA: 138.54 Sell
200-day SMA: 126.19 Sell
8-day EMA: 126.73 Sell
20-day EMA: 130.78 Sell
50-day EMA: 134.9 Sell
200-day EMA: 128.87 Sell

MIRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 41.55 Sell
50-day SMA: 40.65 Sell
200-day SMA: 31.03 Buy
8-day EMA: 40.34 Sell
20-day EMA: 40.95 Sell
50-day EMA: 39.41 Sell
200-day EMA: 32.8 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Mirum Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):